Semaglutide denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Semaglutide as Non-Formulary

A non-formulary denial from UHC means that semaglutide is not included on your specific plan's drug list at a covered tier, or is listed with restrictions — such as requiring prior authorization or step therapy — that were not satisfied at the time of dispensing. UHC operates multiple formularies across its commercial, Medicare Advantage, and other product lines, so the applicable formulary is plan- and year-specific. Confirming exactly which formulary applies to your benefit year is the first step.

## Why This Denial Is Appealable

Non-formulary status does not eliminate your right to coverage if no covered formulary alternative is clinically appropriate for you. Under ACA Section 2719 and ERISA Section 503, you have the right to request a formulary exception and, if it is denied, to file a full internal appeal followed by independent external review. Many state laws also require insurers to grant formulary exceptions when covered alternatives are clinically contraindicated or have been tried and failed. The external-review window is typically open for approximately four months from the denial date; expedited review is available for urgent situations.

## The Appeal Process

1. Request the formulary exception pathway — UHC must provide a process for members to request coverage of a non-formulary drug on medical grounds. 2. Identify all covered formulary alternatives — obtain the current formulary document and list each covered drug in the same therapeutic category. 3. File the internal appeal or formulary exception request — confirm the deadline from your Explanation of Benefits. 4. Escalate to external review if the internal decision is adverse.

## Documentation to Gather

• Covered-alternative trial history: for each formulary alternative UHC lists, document whether you tried it, dates of use, and why it was inadequate — therapeutic failure, documented intolerance, or a prescriber-documented reason the drug is clinically inappropriate.
• Prescriber exception letter: a letter from the treating physician stating that no covered alternative is appropriate for this patient and explaining the clinical basis, referencing applicable guideline organizations (such as the ADA Standards of Care or Obesity Medicine Association) generically.
• Diagnosis and severity documentation: chart notes and relevant clinical findings establishing the underlying condition and its impact.
• FDA-approved indication confirmation: document that the requested use matches an approved indication on the prescribing label.

## Criteria-Mapping Structure

Review UHC's formulary exception criteria for your plan. For each criterion, provide a direct, chart-supported response. Build a table: "Coverage Criterion / Supporting Document / Date / Provider." The most common reason formulary exception appeals fail is insufficient documentation of alternatives — a complete, dated trial history for each covered alternative closes that gap directly.